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Abstract
Background: Both gravitational loading and the forces generated by muscle contraction have direct effects on
serum markers of bone metabolism. The object of this study was to examine the direct effects of a single session
of resistance exercise or walking on biochemical markers of bone metabolism in participants with low bone mass.
Methods: A total of 150 otherwise healthy female subjects (mean age = 59.1 ± 7.1 years) diagnosed with
osteoporosis or osteopenia were randomly allocated to either a resistance exercise group (RG; n = 50), walking
group (WG; n = 50), or control group (CG; n = 50). Changes in bone-specific alkaline phosphatase (BALP),
carboxy-terminal cross-linked telopeptide of type I collagen (CTX), and serum sclerostin concentrations were
measured before and immediately after a single exercise intervention.
Results: There was no significant change in BALP values in any of the groups. Sclerostin levels increased in the RG
and WG, and there was significant difference between the WG and CG after the exercise intervention (P < 0.01).
In contrast, the changes in CTX concentrations from baseline were significant in the RG (P < 0.01) but not in the WG
(P = 0.11), and there was a significant difference between resistance exercise and walking (P < 0.01).
Conclusions: In participants with low bone mass, resistance exercise influenced the serum concentrations of CTX,
a marker of bone resorption, but walking did not.
Trial registration: Current Controlled Trials ISRCTN16329455; retrospectively registered on 05/05/2016.
Keywords: Low bone mass, Exercise, Walking, BALP, CTX, Sclerostin
Background
Biochemical markers of bone metabolism that reflect the
cellular activity related to the formation and resorption
of bone are useful in monitoring physical activity, and
can help us understand the effects of exercise on bone
[1]. The specific mechanisms by which physical exercise
exerts its effects on bone metabolism have not yet been
fully elucidated. “Bone quality” can be determined by sev-
eral parameters, including the extent of mineralization,
the number and distribution of microfractures, the rate of
osteocyte apoptosis, and changes in the collagenous bone
matrix [2].
The anabolic effect of physical exercise on osseous tissue
is related to mechanical effort, although the osteogenic re-
sponse may also be influenced by other factors [3]. Physical
loads associated with exercise impact bone mass and struc-
ture by causing dynamic changes to local mechanical con-
ditions, which stimulate resident osteocytes through fluid
shifts in their canalicular network. These osteocytes then
produce signaling molecules that regulate bone formation
and absorption by osteoblast and osteoclasts [4]. Bone
tissue has an intrinsic “mechanostat” that regulates func-
tional adaptation to stresses [5]. Bone deformation of
1500–3000 με (physiological overload) induces modeling of
the bone cortex, while that of 100–300 με induces bone
multicellular unit (BMU) remodeling. Strain below 100 με* Correspondence: gabriella.gombos@etk.pte.hu
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is associated with bone loss (disuse atrophy), and fractures
may occur with pathological overload [5].
Bone metabolism is influenced by several local factors
including the receptor activator of nuclear factor ĸ B
(RANK) ligand (RANKL) and osteoprotegerin (OPG)
cytokine system, inflammatory cytokines, growth factors,
bone morphogenetic proteins, transforming growth factor,
prostaglandins, colony stimulating factors, and interleukins
[6, 7]. RANKL, a product of osteoblasts, lymphocytes, and
bone marrow cells, is the most powerful stimulator of
osteoclastogenesis [6]. It exerts its activity by binding to
RANK on the cell surface of osteoclast progenitor cells and
stimulating their differentiation to mature osteoclasts. OPG
blocks the binding of RANKL to RANK and regulates bone
resorption by inhibiting osteoclast differentiation [8].
Bone mass can be measured well by densitometry; how-
ever, it is more difficult to accurately examine bone struc-
ture and strength in live tissue. Some substances produced
during bone remodeling are specific biochemical markers
of bone metabolism. Products of active osteoblasts can
serve as markers of bone formation; serum concentrations
of these markers reflect osteoblast function during specific
phases of bone formation [9]. Alkaline phosphatase is a ubi-
quitous tetramer enzyme bound to the cell membrane [9].
In bone, bone-specific alkaline phosphatase (BALP) is
present on the surface of osteoblasts and plays an import-
ant role in osteoid production and mineralization [10, 11].
Cross-linked telopeptides of type I collagen include C-
terminal (CTX, carboxy-terminal cross-linked telopeptide)
and N-terminal (NTX, amino-terminal cross-linked telo-
peptide). These fragments can be produced via different
collagen degradation pathways. CTX and NTX are released
during the cleavage of cathepsin K [12]. Several assays are
available that examine the structural variations in peptide
sequences in the CTX [13, 14] and CTX is one of the most
sensitive and specific markers of osteoclast-mediated colla-
gen degradation [15]. In addition to osteoblasts and osteo-
clasts, osteocytes also play an important role in the process
of bone remodeling, mainly in its terminal stage, through
the production of regulatory factors such as sclerostin
(sclerostin gene: SOST). Sclerostin acts on bone surface
osteoblasts to inhibit their activity and promote apoptosis
[16]. During normal physiological states, the protein scler-
ostin is differentially expressed in response to mechanical
loading, inflammatory molecules such as prostaglandin E2,
and hormones such as parathyroid hormone and estrogen
[17]. Relatively few studies have researched the effects of
physical training on sclerostin levels. Serum concentrations
of sclerostin have been shown to be increased by
immobilization [18, 19], decreased by physical activity in
premenopausal women [20], and to remain steady in phys-
ically active postmenopausal women [21].
Weight-bearing and resistance exercises that improve
muscle strength are essential for preserving the health of
the musculoskeletal system [22]. Coordination, self-
assurance, and appropriate muscular strength help to pre-
vent falls and preserve bone mass by stimulating bone
formation and reducing bone resorption [23]. Training
programs aimed at preserving bone health should incorp-
orate three basic components: 1) impact exercise, such as
brisk walking or jogging; 2) strength training with weights;
and 3) balance training [24], while lower-impact exercises,
such as walking, have minimal effects on density [25]. In
contrast to aerobic exercise training, resistance training
may have more profound site-specific effects on bone, and
progressive resistance training has further advantages in
patients with osteoporosis (OP) due to the resulting
improvements in muscle strength, mass, and balance [26].
The purpose of this study was to describe the acute
response of plasma markers of bone formation (BALP)
and resorption (CTX and sclerostin) to a single session of
either walking or resistance exercise.
Methods
Participants
A total of 150 female subjects diagnosed with osteoporosis/
osteopenia (mean age: 58.5 ± 7.5 years) were included in
this study. Untreated subjects with recently diagnosed
osteoporosis/osteopenia were recruited through a large-
scale screening program promoted by the Department of
Rheumatology at the Zala County Hospital, Hungary, and
implemented through a network of family doctors. The
needed sample size was calculated based on expected effect
size and study power. There are previous studies in similar
contexts with similar interventions which enable exact esti-
mations (d = 0.3) [27, 28]. Thus, setting alpha risk to 0.05
and power to 0.08, a sample of 50 per group was needed
for two-tailed tests. Nearly 1400 women were examined;
712 were diagnosed as having osteoporosis/osteopenia and
65 of these were excluded because of other health condi-
tions. Thereafter, the women were contacted in random
order until 150 had agreed to participate in our study. The
participants were randomly assigned to a resistance exercise
group (RG; n = 50), walking group (WG; n = 50), or control
group (CG; n = 50). Exclusion criteria included (1) any
condition influencing calcium and bone metabolism
(except dietary calcium and Vitamin D supplementation),
(2) ongoing hormone replacement therapy, (3) any known
endocrine/metabolic, renal, or hepatic disease (e.g., hypo-
gonadism, hyperthyroidism, hyperparathyroidism, or in-
creased glucocorticoid levels), (4) any physical injury
(orthopedic, rheumatologic) hindering the performance of
physical activity, (5) osseous fracture of any origin during
the previous 6 months, (6) a diagnosis of cardiovascular dis-
ease or uncontrolled hypertension, (7) any non-antibiotic
medication within the past year, including steroids of any
type, thyroid hormones, diuretics, or anticoagulants, and
(8) any antibiotic use within the last 6 months.
Gombos et al. BMC Musculoskeletal Disorders  (2016) 17:254 Page 2 of 8
Ethical approval for this study was issued by the
Regional Committee of Science and Research Ethics and
the Policy Administration Service of Public Health of Zala
County. All participants received written and verbal
information regarding the purpose and procedures of the
study, and all gave their written informed consent before
participation. After the study, appropriate antiporotic
medication was provided to the participants as required.
Study design
Resistance exercise group (RG)
The mean age of the participants in the RG was 60.2 ±
6.9 years. Their exercise session included 8 min of
dynamic warm-up consisting of exercises requiring
movements of large muscle groups and major joints that
incorporated small impacts with the ground (steps, com-
binations of steps, hopping, stretching) [24]. The main
part of the session comprised approximately 30 min of
exercises that included muscle-strengthening and core
stabilization elements. A list of the exercises is provided
in Table 1. All exercises were performed as a continuous
set; this was followed by a 2-min rest period between
sets, and three sets were performed. At the end of the
session an 8 min cool down consisting of walking and
static and dynamic stretches was performed [24]. The
participants familiarized themselves with the exercises
prior to participating in the study session.
Walking group (WG)
The mean age of participants in the WG was 58.7 ±
6.3 years. Their exercise session consisted of moderate
intensity brisk walking (approximately 3–6 metabolic
equivalents) to a rhythm (100 steps/min) provided by a
metronome. In this rhythm, they walked continuously
for 46 min outdoors on even ground (wearing training
shoes). The subjects familiarized themselves with the
walking style prior to participating in the study session.
Control group (CG)
The mean age of participants in the control group was
57.8 ± 8.4 years. These women did not receive any
intervention.
Laboratory tests
Serum samples were collected and concentrations of
markers of bone metabolism were measured at baseline
and immediately after the interventions. Several assistants
Table 1 Exercises performed by the resistance exercise group during the main part of their exercise session
Starting position Description of the exercise Number of repetitions in 1 set
Lying supine with feet on the ground
10 cm apart, arms at sides with
palms down.
Shoulder bridge – The pelvis is slowly lifted with tense
abdominal and gluteal muscles. This position is held
and the knees are alternately extended.
The pelvis is then slowly lowered.
4×/side
Lying supine with the hips
and knees flexed at 90°
One leg with flexed knee is lowered towards the ground
while the contralateral arm is raised vertically.
This position is held 2 s and then the exercise is repeated
with the opposite limbs.
4×/side
Kneeling position, elbows and forearms
on the floor, knees under the hips,
trunk stabilized, spine and pelvis stable.
Swimming - The contralateral arm and leg are simultaneously
raised until level with the trunk. The exercise is then repeated
with the opposite limbs.
4×/side
Static forearm plank. One leg is raised with the knee extended
(lumbar spine in neutral), the position is held for 2 s and
then the leg is slowly lowered.
This is then repeated with the opposite leg.
4×/side
Static low forearm plank. The pelvis in held in a raised position for 2 s
and then lowered.
6x/side
Sitting on a physioball, legs apart,
soles on the ground, hands holding
a green band.
The participant leans forward from the hip to 45° with
shoulders at approximately 150° flexion while stretching the band.
This position is held for 2 s and then the participant slowly
returns to the starting position.
8x
Standing straight with feet hip width
apart and a ball between the
back and a wall.
Ball squatting against a wall – The participant leans into the ball
and squats until the thighs are parallel to the ground.
The arms are raised and this position is held for 2 s.
8x
Standing with feet hip width
apart and tense trunk muscles.
Backward lunge – The knees are bent to a lunge position,
which is held for 2 s before returning to the starting stance.
4×/side
Standing with 1 kg weights
in both hands.
The participant performs a forward lunge while abducting
the arms to 90° and then returns to the starting position.
4×/side
Standing with feet hip width
apart and arms straight in front.
The participant steps right/left and lowers into a side lunge
before returning to the starting position.
4×/side
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performed sample collection simultaneously to ensure
rapid collection within 0–5 min after the exercise sessions.
All baseline blood samples were collected between 8:00
and 8:30 AM to minimize circadian effects. Prior to the
interventions the participants refrained from exercising
for 24 h and fasted overnight. BALP was measured after
lectin precipitation using a photometric assay. Test was
performed on an Olympus AU 480 Chemistry Analyzer
(Brea, USA). CTX was measured by an electrochemilumi-
nescence immunoassay [29, 30]. The reagents for CTX ana-
lysis were purchased from Roche (Mannheim, Germany),
and measurements were made on a Cobase 411 immuno-
chemical analyzer (Mannheim, Germany). Serum sclerostin
(SOST) concentrations were determined by qualitative
sandwich enzyme-linked immunosorbent assay (Biomedica,
Vienna, Austria). The intra-assay CV was 5–6 %, the inter-
assay CV was 2–6 %.
Physiotherapist-conducted interviews
Participants completed a physiotherapist-administered
questionnaire specifically designed to collect demo-
graphic data and medical history for this study. Previous
and existing diseases (e.g., hypertension, heart disease,
bronchial asthma, arthritis, surgical interventions, and
autoimmune diseases), medications and supplements
(such as Vitamin D), lifestyle factors (sports participation,
diet, smoking, and alcohol and coffee consumption), and
current physical activity level were determined using the
international physical activity questionnaire (IPAQ) [31].
The height of the participants was measured on a Seca
medical stadiometer (Birmingham, UK) and their weight
was checked on an Omron digital scale (Osaka, Japan).
Data analysis
All statistical analyses were performed using SPSS (IBM
SPSS, Inc., Version 20.0, 2011). Results are expressed as
means and standard deviations. Data were checked for
normality of distribution by the Kolmogorov-Smirnov test.
Levene’s test was used to test homoscedasticity. For the
clinical parameters, paired t-tests were used to determine
the significance of differences in continuous variables. A
two (time) by three (intervention) analysis of variance
(ANOVA) with repeated measures was conducted to ex-
plore between- and within-group differences and Scheffe
post hoc analysis was used to determine the significance




Participant characteristics are presented in Table 2.
There were no significant baseline differences between
the groups. The BMI values of the participants ranged
from 14.8 to 39.2, with a mean BMI of 27.0 ± 5.4. The
participants’ T-scores varied between −4.7 and −1.0
(mean: −2.1 ± 0.8); 38 participants had osteoporosis and
112 had osteopenia. T-scores did not significantly differ
between the groups (P = 0.31).
Bone biomarkers
Baseline and post-intervention serum BALP, CTX, and
sclerostin concentrations for the RG, WG, and CG are
shown in Table 3. Baseline BALP concentrations ranged
from 15.8 to 71.0 % (mean: 41.8 ± 9.6), CTX levels ranged
from 30.0 to 685.0 pg/mL (mean: 269.8 ± 127.4), and
sclerostin levels ranged from 7.2 to 69.4 pmol/L (mean:
24.4 ± 11.5) for all participants. Post-intervention BALP
concentrations did not significantly differ from baseline
values, and there were no significant between-group dif-
ferences in the change in the means from baseline to post-
intervention (P = 0.21). The RG and CG both experienced
only a non-significant rise from baseline in serum scleros-
tin concentrations, while the WG experienced a signifi-
cant increase in serum sclerostin. Repeated measures
analysis revealed significant group x time interactions (P <
0.001). Paired sample t-tests revealed a significant change
in CTX concentrations from baseline only in the RG, and
repeated measures ANOVA revealed a significant main ef-
fect of the type of the physical activity (P < 0.01). We
Table 2 Baseline characteristics of the participants
Variables RG (n = 50) WG (n = 50) CG (n = 50) P value
Age, years 60.2 ± 6.9 58.7 ± 6.3 57.8 ± 8.4 0.15
Height, cm 162.6 ± 9.8 159.6 ± 6.4 161.7 ± 5.0 0.06
Weight, kg 69.7 ± 11.8 72.7 ± 14.8 69.5 ± 13.0 0.41
BMI, kg/m2 26.3 ± 5.4 27.2 ± 6.1 28.1 ± 3.9 0.24
T-score −2.2 ± 0.7 −1.9 ± 0.9 −2.1 ± 0.7 0.31
PTH, pmol/L 5.0 ± 1.6 5.7 ± 2.6 4.9 ± 1.7 0.21
25-OH-D, nmol/L 25.8 ± 11.2 27.1 ± 17.6 26.8 ± 16.0 0.16
Resting heart
rate, /min









31 (62 %) 37 (74 %) 23 (76 %) 0.21
Smokers, %a 5 (10 %) 6 (12 %) 3 (10 %) 0.43
Physical activity,
kcal/weekc
3075 ± 1546 3150 ± 1687 3190 ± 1543 0.54
Values are means ± SD
Abbreviations: RG resistance exercise group, WG walking group, CG control
group, BMI body mass index, PTH parathyroid hormone, 25-OH-D 25-hydroxy
vitamin D
aAs assessed by baseline questionnaire (prospective participants who
consumed more than the occasional alcoholic drink were ineligible for
this study)
bMinimum 1 cup of strong black coffee daily
cFrom the International Physical Activity Questionnaire
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compared the osteoporotic and osteopenic participants to
determine if there were any differences in the CTX changes
from baseline after our interventions; RG participants who
had osteoporosis experienced a significant decrease in CTX
concentrations post-intervention (P < 0.01), but CTX
concentrations did not change in participants in the WG or
CG (P > 0.05).
Discussion
Direct effect of physical activity on CTX and BALP
concentrations
Elevated levels of CTX indicate increased bone resorption
and excessive bone turnover [10]. In our study, both
resistance exercise and walking induced only a minimal
change in BALP, a marker of osteogenesis; however, CTX
decreased significantly in the participants who performed
resistance exercise, but not in those in the WG. This dif-
ference in CTX response was statistically significant, indi-
cating that a single session of resistance exercise reduces
bone resorption while a single session of walking does not.
This result differs from what would be expected based on
previous reports in the literature. According to Banfi et
al., exercises performed for a short time are insufficient to
change the concentrations of biochemical markers of
bone metabolism. In addition, markers of osteogenesis
have been reported to be more sensitive than markers of
bone resorption to external stresses, and although stimu-
lation of osteoblast and/or osteoclast function is exercise-
dependent the osteoblast/clast response to exercise is not
immediate [32]. It has been reported that BALP expres-
sion by osteoblast precursors transiently increased from
baseline 30 min after in vitro mechanical stimulation, be-
fore returning to prestimulation levels 24 h later [33, 34].
Significant increases in BALP concentrations have also
been shown at the 30th and 50th minutes of cycling, or at
the end of the cycling session [27, 28]. All changes in
BALP returned to baseline within 20 min after exercise
[35]. In the present study, resistance exercise induced an
immediate change in CTX and sclerostin levels, but BALP
concentrations did not respond to the exercise stimulus.
The correlation between bone strength and age-dependent
musculoskeletal loading in women has not been fully eluci-
dated, but exercises that increase bone density in young
women seem to be ineffective in older adults [36].
Previous studies have reported the short-term effects
of different physical activities, including walking [37, 38],
Table 3 BALP, CTX and sclerostin concentrations in the RG, WG, and CG at baseline and post-intervention
Variables RG (n = 50) WG (n = 50) CG (n = 50)
BALP
Baseline [%]a 41.7 ± 12.8 41.8 ± 7.6 42.2 ± 10.4
Post-intervention [%]a 41.8 ± 12.0 42.1 ± 8.4 42.1 ± 10.2
Change [%]b +0.1 ± 5.0 +0.9 ± 2.6 −0.14 ± 0.57
P value 0.33 0.05 0.19
ANOVA P = 0.21
Post hoc tests P RG − CG = 0.90; P RG − WG = 0.47; P WG − CG = 0.23
CTX
Baseline [pg/mL] 303.6 ± 156.8 247.3 ± 106.2 259.1 ± 110.2
Post-intervention [pg/mL] 276.4 ± 143.6 253.9 ± 107.5 256.7 ± 111.2
Change [pg/mL]b −27.2 ± 33.5 +6.6 ± 30.7 −2.4 ± 14.6
P value (paired t) <0.01 0.11 0.37
ANOVA P < 0.01
Post hoc tests P RG − CG < 0.01; P RG − WG < 0.01; P WG − CG = 0.20
SCLEROSTIN
Baseline [pmol/L] 26.8 ± 14.0 23.6 ± 10.0 24.0 ± 8.8
Post-intervention [pmol/L] 29.8 ± 15.7 29.9 ± 10.8 24.2 ± 8.8
Change [pmol/L]b +2.9 ± 8.6 +6.3 ± 12.1 −0.2 ± 8.7
P value 0.08 <0.01 0.49
ANOVA P < 0.01
Post hoc tests P TG − CG = 0.1; P TG − WG = 0.11; P WG − CG < 0.01
Abbreviations: BALP bone specific alkaline phosphatase, CTX C-terminal telopeptide of type-I collagen, RG resistance exercise group, WG walking group, CG
control group
aBALP expressed as a proportion of the total value of serum ALP
bDifference between baseline and post-intervention data
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outdoor jogging [39], aerobic exercise [28, 40, 41], resist-
ance training [42, 43] and cycling [27, 44, 45], on bone
turnover. Gomes-Cabello et al. summarized the effects
of different training programs on bone turnover in a sys-
tematic review, and found that walking only modestly
increased the loads on the skeleton above those caused
by gravity; thus, this type of exercise does not effectively
prevent osteoporosis in older adults. Resistance exercise/
strength training acts as a powerful stimulus to improve
and maintain bone mass during the ageing process. Multi-
component exercise programs that include strength, aer-
obic, and high impact and/or weight-bearing exercise, as
well as whole-body vibration alone or in combination with
exercise, may help to increase, or at least prevent, the
decline in bone mass that occurs with ageing, especially in
postmenopausal women [46].
Previous studies have reported that serum BALP concen-
trations increased [27, 28, 47], decreased [42, 48], or
remained unchanged [37, 38] after physical activity. The as-
sociation of changes in CTX concentrations with different
types of physical activity has been similarly variable [27, 37,
41, 49]. Thus, it is clear that the response of biochemical
markers of bone metabolism to exercise depends on the
type and intensity of the exercise performed. Bone mass is
the net product of bone formation and resorption, which
are tightly regulated by the equilibrium between endogen-
ous/exogenous factors [50]. Biochemical markers of bone
formation and resorption are very responsive to physical
exercise, but their response varies depending on the type of
exercise. Both gravitational loading and the forces gener-
ated by muscle contraction play important roles in stimu-
lating the skeletal response to mechanical loading [51].
Physical activity and sclerostin levels
Normal sclerostin concentrations vary with age and gender.
In premenopausal and postmenopausal women normal
serum sclerostin concentrations are 24.6 ± 5.7 pmol/L and
30.3 ± 8.8 pmol/L, respectively. In this study, the mean
overall sclerostin concentration before exercise was 24.8 ±
11.5 pmol/L. Serum sclerostin levels increase with age in
both genders, probably contributing to the age-dependent
decrease in bone formation [52].
Situations associated with bone resorption are accompan-
ied by increases in serum sclerostin concentrations. Ardawi
et al. demonstrated that even a small increase in physical
loading induced a significant decrease in serum sclerostin
concentrations and a concomitant increase in markers of
bone formation [20]. Spatz et al. confirmed that the mineral
content of bone significantly decreased after 90 days of bed
rest, and this change was accompanied by a significant
increase in serum sclerostin levels [18]. Similarly, postmen-
opausal women who became immobile as a result of stroke
had significantly higher serum sclerostin concentrations
than controls; this was accompanied by a decreased bone
stiffness index determined by quantitative ultrasound [19].
Lombardi et al. studied athletes and found higher sclerostin
levels in females than in males; in addition, sclerostin con-
centrations were higher in males participating in weight-
bearing disciplines than in those who participated in non-
weight-bearing sports [50]. Sheng et al. studied healthy
postmenopausal women and found significantly higher
serum sclerostin levels in those without OP than in those
with OP [53]. Xu et al. found a positive correlation between
serum sclerostin and lumbar spine bone mineral density
and no significant association of serum sclerostin with age
or body mass index in postmenopausal osteoporotic
women [54]. In the present study, serum sclerostin concen-
trations increased by 11 and 26 % in participants in the RG
and WG, respectively. Bone tissue is mechanosensitive [55].
After a mechanical stimulus, sclerostin secreted by osteo-
cytes travels through the osteocyte canaliculi to the bone
surface where it binds to the coreceptors LRP5 and LRP6
(low-density lipoprotein receptor-related protein 5 and 6)
thus preventing Wnt (Wingless-type mouse mammary
tumor virus integration site family member) signaling and
thereby reducing osteoblastogenesis and bone formation
[56]. Bone resorption begins immediately after mechanical
loading and at the same time, but to a lesser extent, bone
formation also begins. Of the parameters that we studied,
sclerostin responded the most quickly to mechanical load-
ing. Treatments that inhibit sclerostin may be a promising
targeted therapy for bone loss of various origins. Both of
the types of physical activity that we studied significantly in-
creased serum sclerostin levels. An antibody that targets
sclerostin, decreasing endogenous levels of sclerostin while
increasing bone mineral density, is currently in phase-III
clinical trials [17]. Thus, if a sclerostin-inhibiting therapy is
introduced, the medication will conceivably be more effect-
ive when applied after physical exercise.
The strength of the present study was that it examined
the direct effects of a single resistance exercise or walking
session on sclerostin and biochemical markers of bone
metabolism. Its further positive features include the
homogeneity of the groups, as well as the careful assess-
ment and exclusion of underlying diseases, medications,
hormone replacement therapies, and other confounding
circumstances. However, our study also had a number of
limitations. It analyzed only the short-term effects of the
exercises. Participants had wide age and T-score ranges,
both of which have been reported to influence bone turn-
over [23]. The intensity of the exercise was not well
adapted to the participants; a higher intensity may have
had more effect on BALP values. In addition, we did not
measure serum osteocalcin concentrations. Although both
osteocalcin and BALP are osteoblast-specific proteins that
are used as markers of bone formation, they are secreted
during different phases of osteoblast development [57].
BALP is expressed by newly differentiated osteoblasts,
Gombos et al. BMC Musculoskeletal Disorders  (2016) 17:254 Page 6 of 8
whereas osteocalcin is secreted by mature osteoblasts [57];
thus, it may have been useful to include measurement of
osteocalcin concentrations in our analysis.
Conclusions
Our findings provide insight into the direct effects of resist-
ance exercises and walking on biochemical markers of bone
metabolism in older adults with low bone mass. Physical
activity of appropriate type, duration, and intensity can
influence bone turnover, causing a detectable change in
serum concentrations of biochemical markers of bone
metabolism and in serum sclerostin levels. The results of
the study are consistent with previous reports in the litera-
ture indicating that the forces generated by muscle contrac-
tion play an important role in stimulating bone resorption,
which is evident in the change in CTX concentration after
exercise in the RG group. Further studies may uncover the
long-term effect of resistance training on sclerostin and
Wnt/β-catenin pathway.
Abbreviations
25-OH-D, 25-hydroxy vitamin D; ANOVA, analysis of variance; BALP,
bone-specific alkaline phosphatase; BMI, body mass index; BMU, bone
multicellular unit; CG, control group; CTX, carboxy-terminal cross-linked
telopeptide of type I collagen; DEXA, dual energy x-ray absorptiometry; IPAQ,
international physical activity questionnaire; NTX, amino-terminal cross-linked
telopeptide of type I collagen; OPG, osteoprotegerin; PTH, parathyroid hormone;
RANK, receptor activator of nuclear factor ĸ B; RG, resistance exercise group;
WG, walking group
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